Figure 7.
Microscope images of inhibition of rhodamine incorporation into human metastatic melanoma cells (M14#5). Cells were initially treated with 0 (far left panel), 25 (second from left panel), 50 (second from right panel), or 100 (far right panel) μM exogenous α1(IV)1263-1277 THP for 30 min, followed by treatment with α1(IV)1263-1277 PA liposomes. All liposomes utilized DSPC as the primary lipid (see Table 1).